Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_assertion type Assertion NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_head.
- NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_assertion description "[Pharmacological targeting of these proinflammatory pathways using selective receptor antagonists, or the use of transgenic mice with perturbed cell signaling, demostrated that the activation of IL-1R type 1 and TLR4 by their respective endogenous ligands, i.e., interleukin (IL)-1b and High Mobility Group Box 1, is implicated in the precipitation and recurrence of experimentally induced seizures in rodents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_provenance.
- NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_assertion evidence source_evidence_literature NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_provenance.
- NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_assertion SIO_000772 21967368 NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_provenance.
- NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_assertion wasDerivedFrom befree-20140225 NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_provenance.
- NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_assertion wasGeneratedBy ECO_0000203 NP364355.RAwC7ZNIOpcg71OvnmJ7t4m20tC5FyxdE2aD7GD2eZLg4130_provenance.